Macipah Tablet 10 mg contains Macitentan, an endothelin receptor antagonist (ERA) used primarily for the management of pulmonary arterial hypertension (PAH). PAH is a serious condition characterized by high blood pressure in the arteries of the lungs, which can lead to right heart failure, reduced exercise capacity, and increased morbidity.
Macitentan works by blocking the binding of endothelin-1 to its receptors (ETA and ETB) in pulmonary vascular smooth muscle and endothelial cells. Endothelin-1 is a potent vasoconstrictor that contributes to vascular remodeling, elevated pulmonary arterial pressure, and disease progression in PAH. By inhibiting its action, Macitentan helps to dilate pulmonary arteries, reduce pulmonary vascular resistance, and improve cardiac output, thereby enhancing exercise tolerance and slowing disease progression.
Macipah Tablet 10 mg is formulated for oral administration, offering once-daily dosing for optimal patient compliance and steady therapeutic effect.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Macipah Tablet 10 mg is indicated for:
Pulmonary arterial hypertension (PAH) in adults (WHO Group 1), including idiopathic, heritable, or PAH associated with connective tissue diseases
Reduction of disease progression and improvement in exercise capacity in PAH patients
May be used as monotherapy or in combination with other PAH-specific therapies, such as phosphodiesterase-5 inhibitors or prostacyclin analogs
This therapy is critical for patients with mild to severe PAH, helping to improve functional status, quality of life, and long-term prognosis.
Recommended dosage:
Adults: 10 mg orally once daily, with or without food
The dose may be adjusted by a physician based on clinical response, tolerability, and concomitant medications
Administration guidelines:
Swallow the tablet whole with water; do not crush, split, or chew
Take at the same time each day to maintain consistent drug levels
Regular monitoring of liver function, hemoglobin levels, and pregnancy status is essential during therapy
Pregnancy: Macitentan is teratogenic and strictly contraindicated in pregnant women. Women of childbearing potential must use effective contraception during treatment and for 1 month after discontinuation.
Hepatic impairment: Use cautiously in patients with liver disease; monitor liver enzymes regularly
Hematologic monitoring: Macitentan may cause anemia; periodic hemoglobin assessment is recommended
Drug interactions: Avoid strong CYP3A4 inducers (e.g., rifampicin, phenytoin) as they may reduce Macitentan efficacy; consult a physician regarding potential interactions with other medications
Macipah Tablet 10 mg is generally well tolerated. Common side effects include:
Headache, nasal congestion, or flushing
Fatigue or dizziness
Mild anemia or reduced hemoglobin
Peripheral edema (swelling of hands, feet, or ankles)
Rarely, liver enzyme elevation or severe hypersensitivity reactions
Most side effects are mild to moderate and reversible. Severe or persistent reactions should prompt medical evaluation.
Store in a cool, dry place below 30°C, protected from moisture and light. Keep the tablets in their original packaging and out of reach of children.
Macipah Tablet 10 mg (Macitentan) provides effective, once-daily therapy for pulmonary arterial hypertension, helping to improve exercise capacity, delay disease progression, and enhance quality of life in adult patients with PAH.
Login Or Registerto submit your questions to seller
No none asked to seller yet